BioSpectrum Asia - 2022-05-15

• BACK TO SQUARE ONE?
• Acknowledg­ements
• Oz BUDGET BOLSTERS HEALTHCARE
• China approves Fosun Diagnostic­s’ COVID-19 antigen detection kit
• India lays foundation stone of Global Centre for Traditiona­l Medicine
• Australia launches flagship biological storage facility ‘Biobanking Victoria’
• Taiwan announces establishm­ent of first biomedical supercompu­ter
• Japan approves Novavax’s COVID-19 vaccine for primary, booster immunisati­on
• Korea promotes vaccine developmen­t, biomanufac­turing training for LMICs
• AmoyDx collaborat­es with AstraZenec­a for multiple companion diagnostic­s in China
• Australia’s SpeeDx expands COVID-19 diagnostic­s to include self-collected samples
• Intas Pharma, Comera to develop bio-innovative biologic medicines
• Canary Speech, SMK offer early detection of dementia in Japan
• European Wellness strengthen­s medical care in UAE, Malaysia
• Korean firms back US-based Turn Bio for mRNA therapies
• ow to Comply with the 01 Version of USP?
• Juniper Biologics offers world’s first cell-mediated gene therapy for knee osteoarthr­itis
• Pfizer supports breakthrou­gh healthcare innovation­s in India
• GE Healthcare announces plan to support and accelerate Korean startups
• Argentina launches strategy for comprehens­ive approach to mental health
• MSc EpiBiostat programme to establish African cohort of epidemiolo­gists
• Sudan embraces innovative approach to malaria control
• US creates 3D model for rare neuromuscu­lar disorders
• USFDA approves first COVID-19 treatment for young children
• DNDi accelerate­s life-saving drug discovery research in dengue
• WHO launches report on integrated care for older people
• WHO issues guidelines for treatment of cryptococc­al disease in HIV patients
• WHO backs Pfizer’s Paxlovid for patients with non-severe COVID-19
• Oz BUDGET BOLSTERS HEALTHCARE
• COVID-19 RESPONSE PACKAGE
• Treasury Announceme­nts
• Industry Announceme­nts
• MOST SUPPORTIVE FACTORS ENHANCING INNOVATION AT STARTUPS AND SMEs
• POTENTIAL ROADBLOCKS FACED BY EARLY-STAGE STARTUPS AND SMEs
• Corning HYPERFlask Cell Culture Vessels
• Falcon Cell Culture Multi-Flask
• Tessa Therapeuti­cs picks Wilson W. Cheung as CFO
• Rainer Burkard steps in as Global President of PENTAX Medical
• Edwards Lifescienc­es Korea names Kwon Chang-seop as new CEO
• Hong Kong PolyU builds portable nucleic acid testing device for COVID-19
• Japan develops photocatal­yst for antiviral coating against COVID-19
• Australia finds antimicrob­ial resistance making UTIs more deadly
• Singapore makes further advancemen­t in cancer nanomedici­ne
• India unveils indigenous­ly developed polycentri­c prosthetic knee
• Korea designs COVID-19 detection platform by ‘slowing down light’
• India-Australia collaborat­e for joint PhD programme in S&T
• NTU Singapore to award its own medical degrees from 2029
• Fujitsu launches new research centre in India
• Thermo Fisher introduces Gibco CTS TrueCut Cas9 Protein
• Agilent joins NIIMBL to support for biologics manufactur­ability and Industry 4.0 initiative­s
• PerkinElme­r expands in vivo instrument­s portfolio
• Beckman Coulter brings new automated offering for clinical flow cytometry
• Waters launches Xevo TQ Absolute system
• Bio-Rad enhances multiplex flow cytometry with new dyes
• Target: Malaria-free World

BioSpectrum Asia - 2022-04-15

BioSpectrum Asia - 2022-06-15